Table 1 Clinical and pathological characteristics of node-positive breast cancer patients
From: Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
Variable | All patients ( n =92) |
|---|---|
Age (years) | 51 (27–74)a |
Positive nodes | |
⩽3 | 66 |
>3 | 26 |
Histology | |
IDC | 72 |
other | 20 |
Tumour size (mm) | 25 (8–65) |
ER | |
+ | 79 |
− | 13 |
PR | |
+ | 68 |
− | 24 |
SBR grade | |
I | 19 |
II | 41 |
III | 32 |
NPI (raw values) | 5 (3.16–7.20) |
NPI score | |
1 | 7 |
2 | 51 |
3 | 34 |
Follow-up | |
Global | 8.1 (0.8–10.7) |
Alive | 8.1 (1.9–10.7) |
Dead | 4.8 (0.8–8.1) |
Relapse | 25 |
Death | 18 |
